Project Grant HDTRA12610002
- Federal Grant Award Summary The Defense Threat Reduction Agency (DTRA) awarded a Project Grant of $485,069 to the Trustees of Boston University under the Scientific Research - Combating Weapons of Mass Destruction program (CFDA 12.351) on August 11, 2025, with a completion date of August 10, 2030. The project applies artificial intelligence (AI) and machine learning (ML) methods to accelerate materials discovery for chemical and biological defense applications, specifically targeting...
- This federal Project Grant award of $100,000.00 was provided by the Defense Threat Reduction Agency (DTRA) under the Scientific Research - Combating Weapons of Mass Destruction (CFDA 12.351) program. The award will support research at the University of New Mexico's Health Sciences Center focused on developing an in vitro model for studying alphavirus infection. This research aims to advance scientific knowledge and capabilities for defending against biological threats, which aligns with DTRA's...
- Federal Grant Award Summary The University of Washington received a $500,000 Project Grant award from the Defense Threat Reduction Agency (DTRA) under the Scientific Research - Combating Weapons of Mass Destruction program (CFDA 12.351), effective December 15, 2025, with a completion date of December 14, 2030. The award supports fundamental research and development efforts organized across three complementary research tasks designed to advance scientific understanding and engineering...
- Federal Grant Award Summary Michigan State University received a $550,000 project grant from the Defense Threat Reduction Agency (DTRA) under the Scientific Research - Combating Weapons of Mass Destruction program (CFDA 12.351), awarded on April 28, 2025, with a completion date of April 27, 2030. The award funds the development and refinement of BioSonic, an innovative hyperspectral imaging pump-probe platform designed to track viral phonons and observe viral particles in vivo without...
- Federal Project Grant Award Summary Massachusetts Institute of Technology (MIT) received a $200,000 Project Grant award from the Defense Threat Reduction Agency (DTRA) under the Scientific Research - Combating Weapons of Mass Destruction program (CFDA 12.351), effective February 26, 2025. This no-cost extension award supports research on discovering highly stable materials for adsorption and catalytic decontamination, with performance extending through August 31, 2026. The research will be...
- Federal Grant Award Summary The Defense Threat Reduction Agency (DTRA) awarded $524,588 to The Regents of the University of Colorado (University of Colorado-Denver) on September 17, 2025, under the Scientific Research - Combating Weapons of Mass Destruction program (CFDA 12.351). The project, with an ultimate completion date of September 16, 2027, focuses on creating spatiotemporal inflammation mapping associated with agent exposure. This research initiative supports DTRA's mission to advance...
- Summary of Federal Project Grant Award Panorama Research Incorporated received a $405,000 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) on June 1, 2025, with a completion date of May 31, 2027. The grant funds research focused on targeting dual cancer-specific antigens using novel immunotherapies with a safe and controlled immune booster for the treatment of advanced ovarian cancer. Based on Panorama Research's...
- This Project Grant award, funded by the Defense Threat Reduction Agency (DTRA) under the Scientific Research - Combating Weapons of Mass Destruction (CFDA 12.351) federal grant program, aims to develop methods to facilitate the rapid identification of natural products in extracts and human protein targets. The $481,680 award, with a period of performance from May 1, 2025 to April 30, 2030, will be executed by the Puerto Rico Science, Technology, and Research Trust (PRSTRT), a non-profit research...
- Federal Grant Award Summary Asedasciences Inc. received a $1,050,320 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), with an award date of September 30, 2025 and completion target of September 29, 2028. The company will develop a high-throughput cellular and biomimetic screening platform integrated with machine learning analytics and data visualization capabilities designed to assess neurotoxicity risk. This...
- Federal Grant Award Summary Carnegie Mellon University received a $500,000 Project Grant from the Defense Threat Reduction Agency (DTRA) under the Scientific Research - Combating Weapons of Mass Destruction program (CFDA 12.351), awarded November 10, 2025, with a completion date of November 9, 2030. The award supports the development and demonstration of an integrated metamaterial-based infrared (IR) standoff detection system designed to address key limitations in existing chemical sensing...
Battelle Memorial Institute received a $508,306.42 Project Grant from the Defense Threat Reduction Agency (DTRA) under the Scientific Research - Combating Weapons of Mass Destruction program (CFDA 12.351) to develop an innovative polymeric/protein nanoparticles (PNP) platform for targeted drug delivery against weapons of mass destruction threats. The award, effective February 9, 2026 through February 8, 2031, leverages Battelle's proprietary artificial intelligence and machine learning (AI/ML) model and patented synthesis methodology to optimize PNP design for neuron-targeting applications. The platform utilizes episomal DNA constructs with tetracycline-inducible promoters to enable controlled therapeutic delivery, with applications extending to protection of military personnel exposed to biological threats including viruses, toxins, and chemical agents. The deliverables focus on advancing the technological readiness of the PNP platform, which has demonstrated strong safety profiles in clinical trials and proof-of-concept validation. The AI/ML optimization component will guide synthesis parameters based on target organ specifications and particle size requirements necessary for effective diffusion across neuronal tissue barriers. This research directly supports DTRA's mission to identify and adapt emerging scientific capabilities for countering weapons of mass destruction threats through innovative medical countermeasure development.Federal Project Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $508.3k | 2/9/26 |